Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center

被引:36
|
作者
Hatakeyama, Shingo [1 ]
Yoneyama, Takahiro [1 ]
Hamano, Itsuto [1 ]
Murasawa, Hiromi [1 ]
Narita, Takuma [1 ]
Oikawa, Masaaki [1 ]
Hagiwara, Kazuhisa [1 ]
Noro, Daisuke [1 ]
Tanaka, Toshikazu [1 ]
Tanaka, Yoshimi [1 ]
Hashimoto, Yasuhiro [2 ]
Koie, Takuya [1 ]
Ohyama, Chikara [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Grad Sch Med, Dept Adv Transplant & Regenerat Med, Hirosaki, Aomori 0368562, Japan
来源
BMC UROLOGY | 2013年 / 13卷
基金
日本学术振兴会;
关键词
Renal cell carcinoma; Radical nephrectomy with thrombectomy; Tumor thrombus; Prognostic factors; TUMOR THROMBUS; EXTENSION; NEPHRECTOMY; INVOLVEMENT; SURGERY; IMPACT;
D O I
10.1186/1471-2490-13-47
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Management of renal cell carcinoma (RCC) with tumor thrombus extending to the renal vein and inferior vena cava (IVC) is challenging. The aim of this study was to evaluate the benefit of surgical management in such patients. Methods: From February 1995 to February 2013, 520 patients were treated for RCC at Hirosaki University Hospital, Hirosaki, Japan. The RCC patients with tumor thrombus extending to the renal vein (n = 42) and IVC (n = 43) were included in this study. The records of these 85 patients were retrospectively reviewed to assess the relevant clinical and pathological variables and survival. Prognostic factors were identified by multivariate analysis. The benefit of surgical management was evaluated using propensity score matching to compare overall survival between patients who received surgical management and those who did not. Results: RCC was confirmed by pathological examination of surgical or biopsy specimens in 74 of the 85 patients (87%). Sixty-five patients (76%) received surgical management (radical nephrectomy with thrombectomy). Distant metastasis was identified in 45 patients (53%). The proportion of patients with tumor thrombus level 0 (renal vein only), I, II, III, and IV was 49%, 13%, 18%, 14%, and 5%, respectively. The estimated 5-year overall survival rate was 70% in patients with thrombus extending to the renal vein and 23% in patients with thrombus extending to the IVC. Multivariate analysis identified thrombus extending to the IVC, presence of distant metastasis, surgical management, serum albumin concentration, serum choline esterase concentration, neutrophil-lymphocyte ratio, and Carlson comorbidity index as independent prognostic factors. In propensity score-matched patients, overall survival was significantly longer in those who received surgical management than those who did not. Conclusions: Surgical management may improve the prognosis of RCC patients with thrombus extending to the renal vein and IVC.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
    Shingo Hatakeyama
    Takahiro Yoneyama
    Itsuto Hamano
    Hiromi Murasawa
    Takuma Narita
    Masaaki Oikawa
    Kazuhisa Hagiwara
    Daisuke Noro
    Toshikazu Tanaka
    Yoshimi Tanaka
    Yasuhiro Hashimoto
    Takuya Koie
    Chikara Ohyama
    BMC Urology, 13
  • [2] PROGNOSTIC BENEFIT OF SURGICAL MANAGEMENT IN RENAL CELL CARCINOMA PATIENTS WITH THROMBUS EXTENDING TO THE RENAL VEIN AND INFERIOR VENA CAVA: A PROPENSITY SCORE MATCHED ANALYSIS
    Hatakeyama, Shingo
    Yamamoto, Hayato
    Okamoto, Akiko
    Imai, Atsushi
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2014, 191 (04): : E644 - E644
  • [3] Surgical management of renal cell carcinoma with associated tumor thrombus extending into the inferior vena cava: A 10-year single-center experience
    Topaktas, Ramazan
    Urkmez, Ahmet
    Tokuc, Emre
    Kayar, Ridyan
    Kanberoglu, Huseyin
    Ozturk, Metin Ishak
    TURKISH JOURNAL OF UROLOGY, 2019, 45 (05): : 345 - 350
  • [4] Management of Renal Cell Carcinoma With Tumor Thrombus in Renal Vein and the Inferior Vena Cava
    Qi, Jun
    Gu, Zhengqin
    Chen, Fang
    Shen, Haibo
    Chen, Jianhua
    Zhang, Liang
    Wang, Weiming
    ANNALS OF VASCULAR SURGERY, 2010, 24 (08) : 1089 - 1093
  • [5] Surgical management of renal cell carcinoma with inferior vena cava thrombus
    Lok, Hon-Ting
    Chan, Eddie S. Y.
    Hou, Simon S. M.
    Yip, Sidney K. H.
    Ng, Chi-Fai
    SURGICAL PRACTICE, 2014, 18 (02) : 60 - 66
  • [6] Prognostic Benefit of Surgical Management of Renal Cell Carcinoma Invading the Inferior Vena Cava
    Mastoraki A.
    Mastoraki S.
    Tsikala-Vafea M.
    Papanikolaou I.S.
    Lazaris A.
    Smyrniotis V.
    Arkadopoulos N.
    Indian Journal of Surgical Oncology, 2017, 8 (1) : 14 - 18
  • [7] Surgical Management of Inferior Vena Cava Tumor Thrombus in Patients with Renal Cell Carcinoma
    Kayalar, Nihan
    Ozkaynak, Berk
    Gumus, Funda
    Kuplay, Huseyin
    Nuhoglu, Baris
    Erentug, Vedat
    JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, 2013, 3 (02): : 47 - 52
  • [8] Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava
    Jibiki, M
    Iwai, T
    Inoue, Y
    Sugano, N
    Kihara, K
    Hyochi, N
    Sunamori, M
    JOURNAL OF VASCULAR SURGERY, 2004, 39 (04) : 829 - 835
  • [9] Laparoscopic Management of Advanced Renal Cell Carcinoma With Renal Vein and Inferior Vena Cava Thrombus
    Bansal, Rahul Kumar
    Tu, Hin Yu Vincent
    Drachenberg, Darrel
    Shayegan, Bobby
    Matsumoto, Edward
    Whelan, J. Paul
    Kapoor, Anil
    UROLOGY, 2014, 83 (04) : 812 - 816
  • [10] Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus
    Kaplan, S
    Ekici, S
    Dogan, R
    Demircin, M
    Özen, H
    Pasaoglu, I
    AMERICAN JOURNAL OF SURGERY, 2002, 183 (03): : 292 - 299